Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Am J Ophthalmol. 2018 Aug 6;195:154–160. doi: 10.1016/j.ajo.2018.07.045

FIGURE 1.

FIGURE 1.

Kaplan-Meier survival analysis in 240 patients with uveal melanoma using Tumor-Node-Metastasis staging and gene expression profiling/PRAME classification. (Top left) Survival curves are shown using all Tumor-Node-Metastasis stages except stage IV. (Middle left) Comparisons of log-rank statistics are shown between Tumor-Node-Metastasis stages. (Bottom left) Survival curves are shown using optimized Tumor-Node-Metastasis categories. (Top right) Survival curves are shown using all gene expression profiling/PRAME categories. (Middle right) Comparisons of log-rank statistics are shown between gene expression profiling/PRAME categories. (Bottom right) Survival curves are shown using optimized gene expression profiling/PRAME categories.